Silk Road Medical Stock News

SUNNYVALE, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi

The heavy selling pressure might have exhausted for Silk Road Medical (SILK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street a

Silk Road Medical Inc (SILK) shares closed today at 0.8% above its 52 week low of $36.75, giving the company a market cap of $1B. The stock is currently down 13.0% year-to-date, down 32.6% over the past 12 months, and up 2.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 3.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 167.8% The company's stock price performance over the past 12 months lags the peer average by 65.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

SUNNYVALE, Calif., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company

SUNNYVALE, Calif., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi

Equities research analysts expect Silk Road Medical, Inc (NASDAQ:SILK) to report sales of $26.76 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for Silk Road Medicals earnings. The lowest sales estimate is $25.80 million and the highest is $27.44 million. Silk Road Medical reported sales of $21.13 million []

Equities analysts predict that Silk Road Medical, Inc (NASDAQ:SILK) will announce sales of $26.76 million for the current quarter, Zacks reports. Four analysts have provided estimates for Silk Road Medicals earnings, with the highest sales estimate coming in at $27.44 million and the lowest estimate coming in at $25.80 million. Silk Road Medical posted sales []

Silk Road Medical (NASDAQ:SILK) had its price objective trimmed by Argus from $70.00 to $60.00 in a report issued on Monday, The Fly reports. The brokerage currently has a buy rating on the stock. Several other equities analysts have also issued reports on SILK. Piper Sandler cut their price target on Silk Road Medical from […]

Silk Road Medical, Inc (NASDAQ:SILK) hit a new 52-week low during trading on Tuesday after Argus lowered their price target on the stock from $70.00 to $60.00. Argus currently has a buy rating on the stock. Silk Road Medical traded as low as $42.90 and last traded at $43.19, with a volume of 8709 shares […]

Equities research analysts predict that Silk Road Medical, Inc (NASDAQ:SILK) will report $26.76 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for Silk Road Medicals earnings, with the highest sales estimate coming in at $27.44 million and the lowest estimate coming in at $25.80 million. []

Wall Street brokerages expect that Silk Road Medical, Inc (NASDAQ:SILK) will announce ($0.38) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Silk Road Medicals earnings. The lowest EPS estimate is ($0.42) and the highest is ($0.35). Silk Road Medical posted earnings per share of ($0.49) during []

Equities research analysts forecast that Silk Road Medical, Inc (NASDAQ:SILK) will post ($0.38) earnings per share for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for Silk Road Medicals earnings, with the highest EPS estimate coming in at ($0.35) and the lowest estimate coming in at ($0.42). Silk Road Medical []

Silk Road Medical (NASDAQ:SILK) had its target price trimmed by SVB Leerink from $75.00 to $66.00 in a report issued on Wednesday morning, Analyst Price Targets reports. The firm currently has an outperform rating on the stock. SVB Leerink also issued estimates for Silk Road Medicals Q4 2021 earnings at ($0.42) EPS, FY2021 earnings at []

SUNNYVALE, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi

Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q3 2021 Results - Earnings Call Transcript